Page last updated: 2024-09-05

substance p (1-4) and losartan potassium

substance p (1-4) has been researched along with losartan potassium in 1 studies

Compound Research Comparison

Studies
(substance p (1-4))
Trials
(substance p (1-4))
Recent Studies (post-2010)
(substance p (1-4))
Studies
(losartan potassium)
Trials
(losartan potassium)
Recent Studies (post-2010) (losartan potassium)
180024,3902,4935,408

Protein Interaction Comparison

ProteinTaxonomysubstance p (1-4) (IC50)losartan potassium (IC50)
Bile salt export pumpHomo sapiens (human)8.53
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.0082
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0049
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0082
5-hydroxytryptamine receptor 1AMus musculus (house mouse)0.0082
Type-1 angiotensin II receptorCavia porcellus (domestic guinea pig)0.018

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berthou, C; Bourquard, P; Eveillard, JR; Hardy, E; Ianotto, JC; Le Gall, C; Morice, P; Ngo-Sack, F; Ugo, V1

Other Studies

1 other study(ies) available for substance p (1-4) and losartan potassium

ArticleYear
Inhibitory effect of the substance P and its derivative on erythropoietin-independent growth of erythroid progenitors in polycythemia vera.
    Leukemia research, 2008, Volume: 32, Issue:5

    Topics: Cell Differentiation; Cell Proliferation; Cell Survival; Erythroid Precursor Cells; Erythropoietin; GTP-Binding Proteins; Humans; Peptide Fragments; Polycythemia Vera; Receptors, Tachykinin; RNA, Messenger; Substance P

2008